U.S. markets close in 2 hours 6 minutes
  • S&P 500

    4,225.85
    -6.75 (-0.16%)
     
  • Dow 30

    35,018.97
    +241.21 (+0.69%)
     
  • Nasdaq

    13,530.50
    -221.73 (-1.61%)
     
  • Russell 2000

    2,248.07
    -23.56 (-1.04%)
     
  • Crude Oil

    64.97
    +0.07 (+0.11%)
     
  • Gold

    1,837.50
    +6.20 (+0.34%)
     
  • Silver

    27.49
    +0.01 (+0.05%)
     
  • EUR/USD

    1.2162
    -0.0006 (-0.05%)
     
  • 10-Yr Bond

    1.5910
    +0.0140 (+0.89%)
     
  • GBP/USD

    1.4141
    +0.0151 (+1.08%)
     
  • USD/JPY

    108.8550
    +0.2730 (+0.25%)
     
  • BTC-USD

    57,179.87
    -264.06 (-0.46%)
     
  • CMC Crypto 200

    1,527.62
    -33.68 (-2.16%)
     
  • FTSE 100

    7,123.68
    -6.03 (-0.08%)
     
  • Nikkei 225

    29,518.34
    +160.52 (+0.55%)
     

Praxsyn Capital Operational in New York.

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

WEST PALM BEACH, Florida, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Praxsyn (OTC:PXYN, the “Company”) is pleased to announce that its wholly-owned subsidiary, Praxsyn Capital Corporation (“PraxCapital”) has commenced operations in the State of New York, purchasing pools of medical receivables under New York’s No-Fault system.

Furthermore, PraxCapital has agreed terms with its private equity partner, allowing for up to $5,000,000 in deployable capital for the remainder of the year, with increases as needed into 2020.

About Praxsyn Corporation

Headquartered in West Palm Beach, Florida, Praxsyn Corporation works to realize the vision of medical professionals to improve the lives of their patients. Additional company information can be found at www.praxsyncorp.com.

With a mid-market private equity firm that invests in growth companies, recapitalizes or backs new executives.

Forward-Looking Statements

This press release contains forward-looking statements that are subject to many risks and uncertainties. Forward-looking statements include, among other things, statements regarding our intentions, beliefs, projections, outlook, analyses or current expectations. Such risks and uncertainties include, among others, the inherent uncertainties associated with developing new products or technologies, regulatory approvals, unexpected expenditures, the ability to raise the additional funding needed to continue to pursue Praxsyn's business and product development plans and overall market conditions. These forward-looking statements are made as of the date of this press release, and Praxsyn assumes no obligation to update the forward-looking statements.

We may use terms such as “projects,” “believes,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “may,” “could,” “might,” “will,” “should,” “approximately,” or other words that convey the uncertainty of future events or outcomes to identify these forward-looking statements. Although we believe that we have a reasonable basis for each forward-looking statement contained herein, we caution you that forward-looking statements are not guarantees of future performance and that our actual results may differ materially from the forward-looking statements contained in this press release. As a result of these factors, we cannot assure you that the forward-looking statements in this press release will prove to be accurate.

Investor Contact:

Email: investors@praxsyncorp.com